Clinical trials: latest news

Clinical trials resources

  • Clinical trials

    A clinical trial is a study in which a new treatment is assessed.There are legal requirements on how a trial should be run.If you choose to join a...

    From: Factsheets

    Information level Level 2
  • Thinking about joining a clinical trial?

    Before you make a decision about joining a clinical trial, make sure you fully understand what’s involved.There will be benefits and risks to joining any clinical trial.Discuss...

    From: Factsheets

    Information level Level 2

Clinical trials features

Clinical trials in your own words

Clinical trials news from aidsmap

More news

Clinical trials news selected from other sources

  • While The NHS Drags Its Heels On PrEP, This Is How Men Are Being Affected

    Although NHS England increased places in the PrEP Impact Trial to 13,000 participants in summer and recently said it hopes to extend this to 26,000 before 2020, it is yet to confirm when these places will become available – or what will happen when the three-year trial is up. Around 40% of trial clinics across England are currently turning away gay and bisexual men due to oversubscription, according to the Terrence Higgins Trust. Six men who’ve failed to access PrEP have told HuffPost UK the experience has left them feeling “depressed”, “anxious” and “frustrated”.

    12 February 2019 | Huffington Post
  • Correlation between HIV, rectal gonorrhea could help PrEP trial designs

    Rectal gonorrhea incidence may serve to estimate what HIV incidence would have been had trial participants not received PrEP, according to study findings.

    12 February 2019 | Healio
  • Family duty is a powerful force in China. Is that why so many couples signed up for the ‘CRISPR babies’ experiment?

    Young adults in China feel a powerful cultural obligation to marry and have kids, but that life plan suddenly looks unattainable to people told they’re infected with HIV, particularly for the many who can’t afford or are unaware of treatments that would allow them to have uninfected children. So when an ambitious scientist offered HIV-positive men and their spouses what seemed to be a way out of this despair, several hundred couples in China jumped at the chance, expressing interest in a clinical trial that promised to deliver them babies forever protected from HIV infections.

    15 January 2019 | STAT
  • The HIV/AIDS Activists Transformed Genetic Engineering

    Over the past decade, a group of HIV activists has helped pioneer gene therapy.

    20 December 2018 | The Atlantic
  • Community Recommendations for Clinical Research Involving Antiretroviral Treatment Interruptions in Adults

    Scientists working to develop a cure for HIV infection sometimes need to conduct clinical trials in which participants are asked to temporarily interrupt ART, which contradicts the recommendations and guidelines for people with HIV under medical care.

    15 November 2018 | TAG
  • How to evaluate PrEP and vaccines: urgency for next generation compounds

    Several presentations at R4P 2018 looked at the new challenges of evaluating efficacy of new PrEP and vaccine candidates.

    05 November 2018 | HIV i-Base
  • STEPS V: HIV cure community workshop in Glasgow

    STEPS, a community initiative to design the pathway to a long-term remission of HIV infection, has reached its 5th edition in Glasgow. This year the theme of the meeting that was held just before the opening of the HIV Drug Therapy Congress was ‘socio-behavioural science and ethics around HIV cure research’.

    01 November 2018 | EATG
  • Making Clinical Trials of PrEP More Inclusive of Women, No Matter Their Pregnancy Status

    Three new trials of HIV prevention drugs seek to answer directly a question that researchers inside and outside the field of HIV have explicitly avoided for years: How do drugs work -- and are they safe -- in pregnant and breastfeeding women?

    01 October 2018 | The Body Pro
  • Meta-analyses were supposed to end scientific debates. Often, they only cause more controversy

    Although the basic rules of the meta-analysis are simple, researchers must make many choices along the way, allowing conscious or unconscious biases to creep in.

    19 September 2018 | Science
  • FRESH program combines basic science with social benefits for women at risk of HIV

    A program established by the Ragon Institute of MGH, MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from two angles -- first, investigating biological factors that modulate infection risk and the early immunologic events following viral exposure, and second, alleviating the socioeconomic factors that limit opportunities for young women, the group at greatest risk in the region hit hardest by the HIV epidemic.

    16 September 2018 | Eurekalert Inf Dis
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.